HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter Study

Document type :
Journal articles
Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-03623633
Contributor : François Bertucci Connect in order to contact the contributor
Submitted on : Tuesday, March 29, 2022 - 6:06:45 PM
Last modification on : Tuesday, May 3, 2022 - 4:56:34 PM

Identifiers

Citation

Almudena Callejo, Sara Faouzi, Olivier Bouché, F. Bertucci, Thomas Chevalier, et al.. Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter Study. Targeted Oncology, Springer Verlag (Germany), 2021, 16 (4), pp.485-492. ⟨10.1007/s11523-021-00820-7⟩. ⟨hal-03623633⟩

Share

Metrics

Record views

4